{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:17:15Z","timestamp":1777396635454,"version":"3.51.4"},"reference-count":153,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,12,6]]},"abstract":"<jats:p>The traits of Alzheimer\u2019s disease (AD) include amyloid plaques made of A\u03b21-40 and A\u03b21-42, and neurofibrillary tangles by the hyperphosphorylation of tau protein. AD is a complex disorder that is heterogenous in genetical, neuropathological, and clinical contexts. Current available therapeutics are unable to cure AD. Systems medicine is a strategy by viewing the body as a whole system, taking into account each individual\u2019s unique health profile, provide treatment and associated nursing care clinically for the patient, aiming for precision. Since the onset of AD can lead towards cognitive impairment, it is vital to intervene and diagnose early and prevent further progressive loss of neurons. Moreover, as the individual\u2019s brain functions are impaired due to neurodegeneration in AD, it is essential to reconstruct the neurons or brain cells to enable normal brain functions. Although there are different subtypes of AD due to varied pathological lesions, in the majority cases of AD, neurodegeneration and severe brain atrophy develop at the chronic stage. Novel approaches including RNA based gene therapy, stem cell based technology, bioprinting technology, synthetic biology for brain tissue reconstruction are researched in recent decades in the hope to decrease neuroinflammation and restore normal brain function in individuals of AD. Systems medicine include the prevention of disease, diagnosis and treatment by viewing the individual\u2019s body as a whole system, along with systems medicine based nursing as a strategy against AD that should be researched further.<\/jats:p>","DOI":"10.3233\/jad-230739","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T11:35:11Z","timestamp":1700220911000},"page":"1411-1426","source":"Crossref","is-referenced-by-count":5,"title":["Systems Medicine as a Strategy to Deal with Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"96","author":[{"given":"Xiao Xue","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Health Management, Centre of General Practice, The Seventh Affiliated Hospital, Southern Medical University, Lishui Town, Nanhai District, Foshan City, Guangdong Province, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie Bangzhe","family":"Zeng","sequence":"additional","affiliation":[{"name":"Benjoe Institute of Systems Bio-Engineering, High Technology Park, Xinbei District, Changzhou City, Jiangsu Province, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-230739_ref1","first-page":"391","article-title":"Alzheimer\u2019s disease facts and figures","volume":"16","author":"Alzheimer\u2019s Association","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230739_ref2","doi-asserted-by":"crossref","unstructured":"(2022) Alzheimer\u2019s disease facts and figures. Alzheimers Dement 18, 700\u2013789.","DOI":"10.1002\/alz.12638"},{"key":"10.3233\/JAD-230739_ref3","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(96)10203-8","article-title":"Auguste D and Alzheimer\u2019s disease","volume":"349","author":"Maurer","year":"1997","journal-title":"Lancet"},{"key":"10.3233\/JAD-230739_ref4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/alz.12724","article-title":"Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: A cross-sectional and longitudinal study in the AIBL cohort","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230739_ref5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF02866241","article-title":"\u00dcber eigenartige Krankheitsf\u00e4lle des sp\u00e4teren Alters","volume":"4","author":"Alzheimer","year":"1911","journal-title":"Z Gesamte Neurol Psychiatr"},{"key":"10.3233\/JAD-230739_ref6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2012.08.020","article-title":"Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. 1984","volume":"425","author":"Glenner","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-230739_ref7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3892\/mmr.2012.774","article-title":"The amyloid-\u03b2 isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer\u2019s disease","volume":"5","author":"Portelius","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.3233\/JAD-230739_ref8","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1016\/j.neuron.2022.06.021","article-title":"Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer\u2019s disease","volume":"110","author":"Otero-Garcia","year":"2022","journal-title":"Neuron"},{"key":"10.3233\/JAD-230739_ref9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","article-title":"cGAS-STING drives ageing-related inflammation and neurodegeneration","volume":"620","author":"Gulen","year":"2023","journal-title":"Nature"},{"key":"10.3233\/JAD-230739_ref10","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.3390\/ijms20174272","article-title":"Neurodegeneration and neuro-regeneration-Alzheimer\u2019s disease and stem cell therapy","volume":"20","author":"Vasic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-230739_ref11","doi-asserted-by":"crossref","DOI":"10.1177\/1177271920964108","article-title":"Clusterin as a potential biomarker of obesity-related Alzheimer\u2019s disease risk","volume":"15","author":"Bradley","year":"2020","journal-title":"Biomark Insights"},{"key":"10.3233\/JAD-230739_ref12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41583-022-00558-9","article-title":"Impaired insulin signalling and allostatic load in Alzheimer disease","volume":"23","author":"De Felice","year":"2022","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-230739_ref13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4239\/wjd.v13.i4.319","article-title":"Cognitive disorder and dementia in type 2 diabetes mellitus","volume":"13","author":"Ortiz","year":"2022","journal-title":"World J Diabetes"},{"key":"10.3233\/JAD-230739_ref14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-230739_ref15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-230739_ref16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ncl.2016.06.009","article-title":"Alzheimer disease and its growing epidemic: Risk factors, biomarkers, and the urgent need for therapeutics","volume":"34","author":"Hickman","year":"2016","journal-title":"Neurol Clin"},{"key":"10.3233\/JAD-230739_ref17","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JAD-230739_ref18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11910-020-01090-y","article-title":"Early-onset Alzheimer\u2019s disease: What is missing in research?","volume":"21","author":"Ayodele","year":"2021","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.3233\/JAD-230739_ref19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/1980-57642020dn14-030004","article-title":"Genetics of dementia: Insights from Latin America","volume":"14","author":"Ramos","year":"2020","journal-title":"Dement Neuropsychol"},{"key":"10.3233\/JAD-230739_ref20","doi-asserted-by":"crossref","first-page":"860529","DOI":"10.3389\/fnagi.2022.860529","article-title":"PSEN1 c.1292C<A variant and early-onset Alzheimer\u2019s disease: A scoping review","volume":"14","author":"Orozco-Barajas","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-230739_ref21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neurobiolaging.2016.07.030","article-title":"Widespread white matter and conduction defects in PSEN1-related spastic paraparesis","volume":"47","author":"Soosman","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-230739_ref22","doi-asserted-by":"crossref","first-page":"104785","DOI":"10.1016\/j.nbd.2020.104785","article-title":"Novel presenilin 1 and 2 double knock-out cell line for validation of PSEN1 and PSEN2 mutations","volume":"138","author":"Pimenova","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-230739_ref23","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1194\/jlr.M600288-JLR200","article-title":"Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol","volume":"47","author":"Anuurad","year":"2006","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-230739_ref24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-230739_ref25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s disease: Pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Neurodegener"},{"key":"10.3233\/JAD-230739_ref26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.stem.2022.07.005","article-title":"Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity","volume":"29","author":"Victor","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JAD-230739_ref27","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer\u2019s disease","volume":"18","author":"Khan","year":"2020","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-230739_ref28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nmeth.2598","article-title":"CRISPR RNA-guided activation of endogenous human genes","volume":"10","author":"Maeder","year":"2013","journal-title":"Nat Methods"},{"key":"10.3233\/JAD-230739_ref29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13195-017-0317-z","article-title":"Neurons derived from sporadic Alzheimer\u2019s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation","volume":"9","author":"Ochalek","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-230739_ref30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/brainsci8020027","article-title":". ABCA7 and pathogenic pathways of Alzheimer\u2019s disease","volume":"8","author":"Aikawa","year":"2018","journal-title":"Brain Sci"},{"key":"10.3233\/JAD-230739_ref31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13195-019-0572-2","article-title":"Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer\u2019s disease","volume":"12","author":"Quan","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-230739_ref32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bcp.2013.11.021","article-title":"TREM2 and the neuroimmunology of Alzheimer\u2019s disease","volume":"88","author":"Hickman","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-230739_ref33","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 is a receptor for \u03b2-amyloid that mediates microglial function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"key":"10.3233\/JAD-230739_ref34","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1007\/s11033-021-06512-9","article-title":"Recent advances on drug development and emerging therapeutic agents for Alzheimer\u2019s disease","volume":"48","author":"Athar","year":"2021","journal-title":"Mol Biol Rep"},{"key":"10.3233\/JAD-230739_ref35","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-230739_ref36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.3233\/JAD-230739_ref37","first-page":"197","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-230739_ref38","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","article-title":"Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy","volume":"615","author":"Chen","year":"2023","journal-title":"Nature"},{"key":"10.3233\/JAD-230739_ref39","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41593-023-01415-3","article-title":"Infiltrating CD8+ T cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model. ,","volume":"26","author":"Jorfi","year":"2023","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-230739_ref40","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.1074\/jbc.R900012200","article-title":"The RNA-induced silencing complex: A versatile gene-silencing machine","volume":"284","author":"Pratt","year":"2009","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-230739_ref41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12943-017-0683-y","article-title":"Nano-based delivery of RNAi in cancer therapy","volume":"16","author":"Xin","year":"2017","journal-title":"Mol Cancer"},{"key":"10.3233\/JAD-230739_ref42","first-page":"506","article-title":"Significance of native PLGA nanoparticles in the treatment of Alzheimer\u2019s disease pathology","volume":"17","author":"Anand","year":"2022","journal-title":"Bioact Mater"},{"key":"10.3233\/JAD-230739_ref43","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3390\/biomedicines10050985","article-title":"Intranasal administration of a TRAIL neutralizing monoclonal antibody adsorbed in PLGA nanoparticles and NLC nanosystems: An study on a mouse model of Alzheimer\u2019s disease","volume":"10","author":"Musumeci","year":"2022","journal-title":"Biomedicines"},{"key":"10.3233\/JAD-230739_ref44","first-page":"570","article-title":"FDA approves patisiran to treat hereditary transthyretin amyloidosis","volume":"14","author":"Wood","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-230739_ref45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-230739_ref46","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/0192623318792537","article-title":"The nonclinical safety profile of GalNAc-conjugated RNAi therapeutics in subacute studies","volume":"6","author":"Janas","year":"2018","journal-title":"Toxicol Pathol"},{"key":"10.3233\/JAD-230739_ref47","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s41591-021-01522-3","article-title":"Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain","volume":"27","author":"Keiser","year":"2021","journal-title":"Nat Med"},{"key":"10.3233\/JAD-230739_ref48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2018.04.034","article-title":"Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer\u2019s disease","volume":"279","author":"Wang","year":"2018","journal-title":"J Control Release"},{"key":"10.3233\/JAD-230739_ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12038-018-9822-x","article-title":"Delivery of BACE1 siRNA mediated by TARBP-BTP fusion protein reduces \u03b2-amyloid deposits in a transgenic mouse model of Alzheimer\u2019s disease","volume":"44","author":"Haroon","year":"2019","journal-title":"J Biosci"},{"key":"10.3233\/JAD-230739_ref50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1389201020666190204141046","article-title":"in vivo evaluation and Alzheimer\u2019s disease treatment outcome of siRNA loaded dual targeting drug delivery system","volume":"20","author":"Zhang","year":"2019","journal-title":"Curr Pharm Biotechnol"},{"key":"10.3233\/JAD-230739_ref51","doi-asserted-by":"crossref","first-page":"120160","DOI":"10.1016\/j.biomaterials.2020.120160","article-title":"MOF-encapsulated nanozyme enhanced siRNA combo: Control neural stem cell differentiation and ameliorate cognitive impairments in Alzheimer\u2019s disease model","volume":"255","author":"Yu","year":"2020","journal-title":"Biomaterials"},{"key":"10.3233\/JAD-230739_ref52","doi-asserted-by":"crossref","first-page":"e2203182","DOI":"10.1002\/smll.202203182","article-title":"Intranasal delivery of BACE1 siRNA and rapamycin by dual targets modified nanoparticles for Alzheimer\u2019s disease therapy","volume":"18","author":"Yang","year":"2022","journal-title":"Small"},{"key":"10.3233\/JAD-230739_ref53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/acsami.1c15305","article-title":"siRNA mediated GSK3\u03b2 knockdown targets insulin signaling pathway and rescues Alzheimer\u2019s disease pathology: Evidence from and studies","volume":"14","author":"Gupta","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.3233\/JAD-230739_ref54","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/iub.2330","article-title":"Brain-targeted co-delivery of \u03b2-amyloid converting enzyme 1 shRNA and epigallocatechin-3-gallate by multifunctional nanocarriers for Alzheimer\u2019s disease treatment","volume":"72","author":"Lv","year":"2022","journal-title":"IUBMB Life"},{"key":"10.3233\/JAD-230739_ref55","doi-asserted-by":"crossref","first-page":"5550938","DOI":"10.1155\/2021\/5550938","article-title":"The potential benefits of nanotechnology in treating Alzheimer\u2019s disease","volume":"2021","author":"Ling","year":"2021","journal-title":"Biomed Res Int"},{"key":"10.3233\/JAD-230739_ref56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.gene.2014.05.031","article-title":"Genetic markers for diagnosis and pathogenesis of Alzheimer\u2019s disease","volume":"545","author":"Kim","year":"2014","journal-title":"Gene"},{"key":"10.3233\/JAD-230739_ref57","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3390\/cells12141911","article-title":"Liquid biopsy in neurological diseases","volume":"12","author":"Malhotra","year":"2023","journal-title":"Cells"},{"key":"10.3233\/JAD-230739_ref58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-1-4939-7704-8_21","article-title":"Quantifying miRNA deregulation in Alzheimer\u2019s disease","volume":"1750","author":"Cardoso","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.3233\/JAD-230739_ref59","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1007\/s12035-019-1500-y","article-title":"Systematic review of miRNA as biomarkers in Alzheimer\u2019s disease","volume":"56","author":"Swarbrick","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-230739_ref60","doi-asserted-by":"crossref","first-page":"15589","DOI":"10.1038\/s41598-022-19862-6","article-title":"Plasma microRNAs as potential biomarkers in early Alzheimer disease expression","volume":"12","author":"Pe\u00f1a-Bautista","year":"2022","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-230739_ref61","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3233\/JAD-220676","article-title":"Inflammation-related microRNAs-146a and -155 are upregulated in mild cognitive impairment subjects among older age population in Montenegro","volume":"90","author":"Rovcanin","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230739_ref62","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1021\/acs.analchem.2c03542","article-title":"Printed electrochemical strip for the detection of miRNA-29a: A possible biomarker related to Alzheimer\u2019s disease","volume":"94","author":"Miglione","year":"2022","journal-title":"Anal Chem"},{"key":"10.3233\/JAD-230739_ref63","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/biomedicines9091272","article-title":"Platelet miRNA biosignature discriminates between dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"9","author":"G\u00e1mez-Valero","year":"2021","journal-title":"Biomedicines"},{"key":"10.3233\/JAD-230739_ref64","doi-asserted-by":"crossref","first-page":"113128","DOI":"10.1016\/j.expneurol.2019.113128","article-title":"microRNA-592 blockade inhibits oxidative stress injury in Alzheimer\u2019s disease astrocytes via the KIAA0319-mediated Keap1\/Nrf2\/ARE signaling pathway","volume":"324","author":"Wu","year":"2020","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-230739_ref65","doi-asserted-by":"crossref","first-page":"10772","DOI":"10.1038\/s41598-020-67460-1","article-title":"Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer\u2019s disease model by increasing the expression of microRNA-146a in hippocampus","volume":"10","author":"Nakano","year":"2020","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-230739_ref66","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1039\/D0CC04249H","article-title":"First dual binder of microRNA-146a and monomeric tau: A novel approach for multitargeted therapeutics for neurodegenerative diseases.","volume":"56","author":"Gabr","year":"2020","journal-title":"Chem Commun (Camb)"},{"key":"10.3233\/JAD-230739_ref67","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.stem.2021.05.001","article-title":"Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer\u2019s disease.","volume":"28","author":"Walgrave","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JAD-230739_ref68","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1093\/hmg\/ddaa179","article-title":"Gene therapy for Alzheimer\u2019s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation","volume":"29","author":"Griciuc","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-230739_ref69","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.brainresbull.2012.05.018","article-title":"microRNA-195 downregulates Alzheimer\u2019s disease amyloid-\u03b2 production by targeting BACE1","volume":"88","author":"Zhu","year":"2012","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-230739_ref70","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxlet.2011.11.032","article-title":"The miR-124 regulates the expression of BACE1\/\u03b2-secretase correlated with cell death in Alzheimer\u2019s disease","volume":"209","author":"Fang","year":"2012","journal-title":"Toxicol Lett"},{"key":"10.3233\/JAD-230739_ref71","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1038\/s41380-020-0824-3","article-title":"microRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer\u2019s disease pathogenesis","volume":"26","author":"Cao","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-230739_ref72","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/bios12121074","article-title":"Recent advances in the roles of microRNA and microRNA-based diagnosis in neurodegenerative diseases","volume":"12","author":"Zhang","year":"2022","journal-title":"Biosensors (Basel)"},{"key":"10.3233\/JAD-230739_ref73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-981-15-4370-8_4","article-title":"Stem cell therapy for Alzheimer\u2019s disease","volume":"1266","author":"Han","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/JAD-230739_ref74","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/scrt227","article-title":"Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an A\u03b2PP\/PS1 transgenic mouse model","volume":"4","author":"Yang","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.3233\/JAD-230739_ref75","doi-asserted-by":"crossref","first-page":"112362","DOI":"10.1016\/j.bbr.2019.112362","article-title":"Hypoxic-conditioned medium from adipose tissue mesenchymal stem cells improved neuroinflammation through alternation of toll like receptor (TLR) 2 and TLR4 expression in model of Alzheimer\u2019s disease rats","volume":"379","author":"Mehrabadi","year":"2020","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-230739_ref76","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","article-title":"Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: A phase I clinical trial","volume":"13","author":"Kim","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-230739_ref77","doi-asserted-by":"crossref","first-page":"113706","DOI":"10.1016\/j.expneurol.2021.113706","article-title":"Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer\u2019s disease","volume":"41","author":"Neves","year":"2021","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-230739_ref78","doi-asserted-by":"crossref","first-page":"102325","DOI":"10.1016\/j.redox.2022.102325","article-title":"MG53 protein rejuvenates hUC-MSCs and facilitates their therapeutic effects in AD mice by activating Nrf2 signaling pathway","volume":"53","author":"Ma","year":"2022","journal-title":"Redox Biol"},{"key":"10.3233\/JAD-230739_ref79","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/sctm.19-0327","article-title":"Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer\u2019s disease","volume":"9","author":"Losurdo","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"10.3233\/JAD-230739_ref80","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3233\/JAD-200026","article-title":"Feasibility and efficacy of intra-arterial administration of embryonic stem cell derived-mesenchymal stem cells in animal model of Alzheimer\u2019s disease","volume":"76","author":"Kim","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230739_ref81","first-page":"458","article-title":"Mesenchymal stem cells modulate SIRT1\/MiR-134\/GSK3\u03b2 signaling pathway in a rat model of Alzheimer\u2019s disease","volume":"9","author":"Abozaid","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-230739_ref82","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000430356","article-title":"Therapeutic effects of transplantation of as-mir-937-expressing mesenchymal stem cells in murine model of Alzheimer\u2019s disease","volume":"37","author":"Liu","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.3233\/JAD-230739_ref83","doi-asserted-by":"crossref","first-page":"14776","DOI":"10.1038\/s41598-018-33017-6","article-title":"Human neural stem cell transplantation improves cognition in a murine model of Alzheimer\u2019s disease","volume":"8","author":"McGinley","year":"2018","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-230739_ref84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12929-020-0622-x","article-title":"Effects of neural stem cell transplantation in Alzheimer\u2019s disease models","volume":"27","author":"Hayashi","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.3233\/JAD-230739_ref85","first-page":"e2006357","article-title":"A nanoformulation-mediated multifunctional stem cell therapy with improved beta-amyloid clearance and neural regeneration for Alzheimer\u2019s disease","volume":"33","author":"Huang","year":"2021","journal-title":"Mater"},{"key":"10.3233\/JAD-230739_ref86","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s12015-021-10321-9","article-title":"Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer\u2019s disease","volume":"18","author":"Campos","year":"2022","journal-title":"Stem Cell Rev Rep"},{"key":"10.3233\/JAD-230739_ref87","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-015-0035-6","article-title":"Human neural stem cells alleviate Alzheimer-like pathology in a mouse model","volume":"10","author":"Lee","year":"2015","journal-title":"Neurodegener"},{"key":"10.3233\/JAD-230739_ref88","doi-asserted-by":"crossref","first-page":"e1046","DOI":"10.1002\/ctm2.1046","article-title":"Monoclonal antibody-mediated immunosuppression enables long-term survival of transplanted human neural stem cells in mouse brain.","volume":"12","author":"McGinley","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.3233\/JAD-230739_ref89","doi-asserted-by":"crossref","first-page":"13936","DOI":"10.3390\/ijms232213936","article-title":"The bHLH transcription factors in neural development and therapeutic applications for neurodegenerative diseases","volume":"23","author":"Lee","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-230739_ref90","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2217\/epi-2020-0409","article-title":"Induced pluripotent stem cell technology: Trends in molecular biology, from genetics to epigenetics","volume":"13","author":"Maali","year":"2021","journal-title":"Epigenomics"},{"key":"10.3233\/JAD-230739_ref91","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13287-020-01741-4","article-title":"Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies","volume":"11","author":"Shankar","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.3233\/JAD-230739_ref92","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00005-021-00640-7","article-title":"Prospects for development of induced pluripotent stem cell-derived CAR-targeted immunotherapies","volume":"70","author":"Mazza","year":"2021","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.3233\/JAD-230739_ref93","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/genes12010112","article-title":"Hereditary optic neuropathies: Induced pluripotent stem cell-based 2D\/3D approaches","volume":"12","author":"Garc\u00eda-L\u00f3pez","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.3233\/JAD-230739_ref94","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00424-021-02536-z","article-title":"Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research","volume":"473","author":"Andrysiak","year":"2021","journal-title":"Pflugers Arch"},{"key":"10.3233\/JAD-230739_ref95","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/nprot.2011.405","article-title":"Directed differentiation of functional astroglial subtypes from human pluripotent stem cells","volume":"6","author":"Krencik","year":"2011","journal-title":"Nat Protoc"},{"key":"10.3233\/JAD-230739_ref96","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/stem.1334","article-title":"Efficient generation of astrocytes from human pluripotent stem cells in defined conditions","volume":"31","author":"Shaltouki","year":"2013","journal-title":"Stem Cells"},{"key":"10.3233\/JAD-230739_ref97","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1523\/JNEUROSCI.0906-12.2013","article-title":"Accelerated high-yield generation of limb-innervating motor neurons from human stem cells","volume":"33","author":"Amoroso","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230739_ref98","first-page":"607","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.3233\/JAD-230739_ref99","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1124\/molpharm.122.000555","article-title":"A complete endocannabinoid signaling system modulates synaptic transmission between human induced pluripotent stem cell-derived neurons","volume":"103","author":"Asher","year":"2023","journal-title":"Mol Pharmacol"},{"key":"10.3233\/JAD-230739_ref100","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0143-22.2022","article-title":"Spontaneous cell cluster formation in human iPSC-derived neuronal spheroid networks influences network activity","volume":"9","author":"H\u00f6rberg","year":"2022","journal-title":"eNeuro"},{"key":"10.3233\/JAD-230739_ref101","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1002\/cpz1.88","article-title":"autologous induced pluripotent stem cell-based cell therapies: Promise, progress, and challenges","volume":"1","author":"Madrid","year":"2021","journal-title":"Curr Protoc"},{"key":"10.3233\/JAD-230739_ref102","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/scd.2019.0201","article-title":"Natural killer cell alloreactivity against human induced pluripotent stem cells and their neuronal derivatives into dopaminergic neurons","volume":"29","author":"de Rham","year":"2020","journal-title":"Stem Cells Dev"},{"key":"10.3233\/JAD-230739_ref103","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41467-017-00926-5","article-title":"MHC matching improves engraftment of iPSC-derived neurons in non-human primates","volume":"8","author":"Morizane","year":"2017","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-230739_ref104","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08797","article-title":"Direct conversion of fibroblasts to functional neurons by defined factors","volume":"463","author":"Vierbuchen","year":"2010","journal-title":"Nature"},{"key":"10.3233\/JAD-230739_ref105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10821","article-title":"Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells","volume":"482","author":"Israel","year":"2012","journal-title":"Nature"},{"key":"10.3233\/JAD-230739_ref106","first-page":"5041","article-title":"Immunoregulatory effect of neuronal-like cells in inducting differentiation of bone marrow mesenchymal stem cells","volume":"20","author":"Xu","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.3233\/JAD-230739_ref107","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/sctm.19-0054","article-title":"Chemotherapy-induced neuropathy and drug discovery platform using human sensory neurons converted directly from adult peripheral blood","volume":"8","author":"Vojnits","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"10.3233\/JAD-230739_ref108","doi-asserted-by":"crossref","first-page":"5340616","DOI":"10.1155\/2019\/5340616","article-title":"The role of 3D printing in medical applications: A state of the art","volume":"2019","author":"Aimar","year":"2019","journal-title":"J Healthc Eng"},{"key":"10.3233\/JAD-230739_ref109","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.3390\/ijms19123972","article-title":"From neuronal differentiation of iPSCs to 3D neuro-organoids: Modelling and therapy of neurodegenerative diseases","volume":"19","author":"Bordoni","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-230739_ref110","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1021\/acs.biomac.2c00626","article-title":"Surface-modified Polypyrrole-coated PLCL and PLGA nerve guide conduits fabricated by 3D printing and electrospinning","volume":"23","author":"Namhongsa","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.3233\/JAD-230739_ref111","doi-asserted-by":"crossref","first-page":"895406","DOI":"10.3389\/fbioe.2022.895406","article-title":"3D-printed hyaluronic acid hydrogel scaffolds impregnated with neurotrophic factors (BDNF, GDNF) for post-traumatic brain tissue reconstruction","volume":"10","author":"Mishchenko","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.3233\/JAD-230739_ref112","doi-asserted-by":"crossref","first-page":"rbac043","DOI":"10.1093\/rb\/rbac043","article-title":"Three-dimensional-printed collagen\/chitosan\/secretome derived from HUCMSCs scaffolds for efficient neural network reconstruction in canines with traumatic brain injury.","volume":"9","author":"Liu","year":"2022","journal-title":"Regen Biomater"},{"key":"10.3233\/JAD-230739_ref113","doi-asserted-by":"crossref","first-page":"2201392","DOI":"10.1002\/advs.202201392","article-title":"Embedded 3D printing in self-healing annealable composites for precise patterning of functionally mature human neural constructs. , e","volume":"9","author":"Kajtez","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.3233\/JAD-230739_ref114","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1109\/TBME.2021.3113653","article-title":"STEER: 3D printed guide for nerve regrowth control and neural interface in non-human primate model","volume":"69","author":"Blasiak","year":"2022","journal-title":"Trans Biomed Eng"},{"key":"10.3233\/JAD-230739_ref115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fbioe.2020.00057","article-title":"3D bioprinting pluripotent stem cell derived neural tissues using a novel fibrin bioink containing drug releasing microspheres","volume":"8","author":"Sharma","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.3233\/JAD-230739_ref116","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1021\/acsbiomaterials.8b01235","article-title":"3D printing of neural tissues derived from human induced pluripotent stem cells using a fibrin-based bioink","volume":"5","author":"Abelseth","year":"2019","journal-title":"ACS Biomater Sci Eng"},{"key":"10.3233\/JAD-230739_ref117","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cell.2019.07.042","article-title":"Reconstruction of 1,000 projection neurons reveals new cell types and organization of long-range connectivity in the mouse brain","volume":"179","author":"Winnubst","year":"2019","journal-title":"Cell"},{"key":"10.3233\/JAD-230739_ref118","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrn3945","article-title":"Neuronal circuits for fear and anxiety","volume":"16","author":"Tovote","year":"2015","journal-title":"Rev Neurosci"},{"key":"10.3233\/JAD-230739_ref119","first-page":"107323","article-title":"Midbrain circuits of novelty processing","volume":"176","author":"Tapper","year":"2020","journal-title":"Learn Mem"},{"key":"10.3233\/JAD-230739_ref120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-030-89439-9_4","article-title":"Neuron-glia interactions and brain circuits","volume":"1359","author":"Linne","year":"2022","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/JAD-230739_ref121","first-page":"4187","article-title":"Circuit formation in the adult brain","volume":"56","author":"Seng","year":"2022","journal-title":"Neurosci"},{"key":"10.3233\/JAD-230739_ref122","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tics.2017.09.012","article-title":"Network design and the brain","volume":"22","author":"Navlakha","year":"2018","journal-title":"Trends Cogn Sci"},{"key":"10.3233\/JAD-230739_ref123","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1039\/C5IB00325C","article-title":"Synthetic biology approaches in cancer immunotherapy, genetic network engineering, and genome editing","volume":"8","author":"Chakravarti","year":"2016","journal-title":"Integr Biol (Camb)"},{"key":"10.3233\/JAD-230739_ref124","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41573-021-00285-3","article-title":"Engineering living therapeutics with synthetic biology","volume":"20","author":"Cubillos-Ruiz","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-230739_ref125","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/bies.201400094","article-title":"Synthetic biology and therapeutic strategies for the degenerating brain: Synthetic biology approaches can transform classical cell and gene therapies, to provide new cures for neurodegenerative diseases.","volume":"36","author":"Agust\u00edn-Pav\u00f3n","year":"2014","journal-title":"Bioessays"},{"key":"10.3233\/JAD-230739_ref126","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11693-014-9154-6","article-title":"Recent advances and opportunities in synthetic logic gates engineering in living cells","volume":"8","author":"Singh","year":"2014","journal-title":"Syst Synth Biol"},{"key":"10.3233\/JAD-230739_ref127","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nbt.2510","article-title":"Synthetic circuits integrating logic and memory in living cells","volume":"31","author":"Siuti","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.3233\/JAD-230739_ref128","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1042\/ETLS20190091","article-title":"Synthetic biology for improving cell fate decisions and tissue engineering outcomes","volume":"3","author":"Vogel","year":"2019","journal-title":"Emerg Top Life Sci"},{"key":"10.3233\/JAD-230739_ref129","doi-asserted-by":"crossref","first-page":"11247","DOI":"10.1038\/ncomms11247","article-title":"A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells","volume":"7","author":"Saxena","year":"2016","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-230739_ref130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymben.2021.03.009","article-title":"Rational design and optimization of synthetic gene switches for controlling cell-fate decisions in pluripotent stem cells","volume":"65","author":"Haellman","year":"2021","journal-title":"Metab Eng"},{"key":"10.3233\/JAD-230739_ref131","first-page":"0005","article-title":"Self-adjusting synthetic gene circuit for correcting insulin resistance","volume":"1","author":"Ye","year":"2017","journal-title":"Biomed Eng"},{"key":"10.3233\/JAD-230739_ref132","first-page":"1305","article-title":"Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment","volume":"9","author":"Kojima","year":"2018","journal-title":"Commun"},{"key":"10.3233\/JAD-230739_ref133","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1021\/sb4001273","article-title":"Retropath: Automated pipeline for embedded metabolic circuits","volume":"3","author":"Carbonell","year":"2014","journal-title":"ACS Synth Biol"},{"key":"10.3233\/JAD-230739_ref134","doi-asserted-by":"crossref","first-page":"103685","DOI":"10.1016\/j.nepr.2023.103685","article-title":"Knowledge and attitudes towards patients with Alzheimer\u2019s disease across different educational levels of nursing and in different care settings: A cross-sectional study","volume":"71","author":"Romem","year":"2023","journal-title":"Nurse Educ Pract"},{"key":"10.3233\/JAD-230739_ref135","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3233\/JAD-221300","article-title":"Incidence of new dementia diagnosis in Veterans admitted to nursing homes after heart failure hospitalization","volume":"94","author":"Bayer","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230739_ref136","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1038\/s41598-023-34173-0","article-title":"Relationship between antidementia medication and fracture prevention in patients with Alzheimer\u2019s dementia using a nationwide health insurance claims database","volume":"13","author":"Hosoi","year":"2023","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-230739_ref137","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/HNP.0000000000000470","article-title":"Biodanza as a nonpharmacological dance movement-based treatment in older people with Alzheimer\u2019s disease: An Italian pilot study in 2 Tuscan nursing homes","volume":"35","author":"Chiesi","year":"2021","journal-title":"Holist Nurs Pract"},{"key":"10.3233\/JAD-230739_ref138","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12904-023-01226-0","article-title":"Using palliative leaders in facilities to transform care for people with Alzheimer\u2019s disease (UPLIFT-AD): Protocol of a palliative care clinical trial in nursing homes","volume":"22","author":"Unroe","year":"2023","journal-title":"BMC Palliat Care"},{"key":"10.3233\/JAD-230739_ref139","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s44228-022-00004-8","article-title":"The ebmt immune effector cell nursing guidelines on CAR-T therapy: A framework for patient care and managing common toxicities","volume":"4","author":"Ellard","year":"2022","journal-title":"Clin Hematol Int"},{"key":"10.3233\/JAD-230739_ref140","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/hae.14822","article-title":"Development of a haemophilia A gene therapy shared decision-making tool for clinicians","volume":"29","author":"Limjoco","year":"2023","journal-title":"Haemophilia"},{"key":"10.3233\/JAD-230739_ref141","first-page":"20","article-title":"Genetics, epigenetics and disease","volume":"22","author":"Casey","year":"2016","journal-title":"Nurs N Z"},{"key":"10.3233\/JAD-230739_ref142","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3390\/ijms20030719","article-title":"Novel approaches for the treatment of Alzheimer\u2019s and Parkinson\u2019s disease","volume":"20","author":"Van Bulck","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-230739_ref143","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1091\/mbc.11.12.4093","article-title":"Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells","volume":"11","author":"Vogelsberg-Ragaglia","year":"2000","journal-title":"Mol Biol Cell"},{"key":"10.3233\/JAD-230739_ref144","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.arr.2012.05.002","article-title":"The function of BMP4 during neurogenesis in the adult hippocampus in Alzheimer\u2019s disease","volume":"12","author":"Xu","year":"2013","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-230739_ref145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuropsychologia.2014.09.019","article-title":"Creativity and the default network: A functional connectivity analysis of the creative brain at rest","volume":"64","author":"Beaty","year":"2014","journal-title":"Neuropsychologia"},{"key":"10.3233\/JAD-230739_ref146","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tics.2015.10.004","article-title":"Creative cognition and brain network dynamics","volume":"20","author":"Beaty","year":"2016","journal-title":"Trends Cogn Sci"},{"key":"10.3233\/JAD-230739_ref147","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S0954579405050406","article-title":"Reflective thinking and mental imagery: A perspective on the development of posttraumatic stress disorder","volume":"17","author":"Kosslyn","year":"2005","journal-title":"Dev Psychopathol"},{"key":"10.3233\/JAD-230739_ref148","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1089\/ten.tea.2014.0557","article-title":"Rebuilding brain circuitry with living micro-tissue engineered neural networks","volume":"21","author":"Struzyna","year":"2015","journal-title":"Tissue Eng Part A"},{"key":"10.3233\/JAD-230739_ref149","doi-asserted-by":"crossref","DOI":"10.1177\/13596535231161488","article-title":"Case report and literature review: A hiccup patient developed encephalitis and duodenal perforation","volume":"28","author":"Kong","year":"2023","journal-title":"Antivir Ther"},{"key":"10.3233\/JAD-230739_ref150","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s12033-023-00699-x","article-title":"Systems medicine for precise targeting of glioblastoma","volume":"65","author":"Zeng","year":"2023","journal-title":"Mol Biotechnol"},{"key":"10.3233\/JAD-230739_ref151","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jbiotec.2008.07.062","article-title":"Synthetic biology and transgenic system biotechnology (Suppl)","volume":"136","author":"Jie Zeng","year":"2008","journal-title":"J Biotechnol"},{"key":"10.3233\/JAD-230739_ref152","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jbiotec.2010.09.890","article-title":"Applied micro-fluidic biochips in systems and synthetic biology. (Suppl)","volume":"150","author":"Jie Zeng","year":"2010","journal-title":"J Biotechnol"},{"key":"10.3233\/JAD-230739_ref153","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jalz.2018.08.004","article-title":"The clinical practice of risk reduction for Alzheimer\u2019s disease: A precision medicine approach","volume":"14","author":"Isaacson","year":"2018","journal-title":"Alzheimers Dement"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-230739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:56Z","timestamp":1777370936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-230739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":153,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-230739","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]}}}